Broadwood Capital Inc
CIK 0001278387 Name as filed on the most recent filing
Filed as Broadwood Capital Inc (178)
1,232 transaction lines · from 178 filings · filed 2007-06-05 to 2026-04-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Insight Molecular Diagnostics Inc. 17 filings
- ISSUER Staar Surgical Co 88 filings
- ISSUER Lineage Cell Therapeutics, Inc. 22 filings
- ISSUER Asterias Biotherapeutics, Inc. 2 filings
- ISSUER Comarco Inc 32 filings
- ISSUER Questcor Pharmaceuticals Inc 8 filings
- ISSUER Palomar Medical Technologies Inc 9 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-27 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 250,923 acquired | 3.64 | 913,133.89 | Form 4, filing 0000919574-26-002414 | |
| 2026-04-27 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-002414 | |
| 2026-04-24 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 38,880 acquired | 3.53 | 137,083.10 | Form 4, filing 0000919574-26-002414 | |
| 2026-04-24 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-002414 | |
| 2026-04-23 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 280,381 acquired | 3.50 | 982,034.45 | Form 4, filing 0000919574-26-002414 | |
| 2026-04-23 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-002414 | |
| 2026-04-20 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 40,690 acquired | 3.88 | 157,966.72 | Form 4, filing 0000919574-26-002306 | |
| 2026-04-20 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-002306 | |
| 2026-04-17 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 40,114 acquired | 3.57 | 143,251.11 | Form 4, filing 0000919574-26-002306 | |
| 2026-04-17 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-002306 | |
| 2026-04-16 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 102,057 acquired | 3.45 | 351,657.80 | Form 4, filing 0000919574-26-002306 | |
| 2026-04-16 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-002306 | |
| 2026-03-13 |
Staar Surgical Co STAA |
P, Open-market purchase | 316,017 acquired | 18.62 | 5,882,656.46 | Form 4, filing 0000919574-26-001617 | |
| 2026-03-13 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-001617 | |
| 2026-03-12 |
Staar Surgical Co STAA |
P, Open-market purchase | 299,432 acquired | 18.12 | 5,424,330.45 | Form 4, filing 0000919574-26-001617 | |
| 2026-03-12 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-001617 | |
| 2026-03-11 |
Staar Surgical Co STAA |
P, Open-market purchase | 54,764 acquired | 17.52 | 959,558.38 | Form 4, filing 0000919574-26-001617 | |
| 2026-03-11 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-001617 | |
| 2026-02-10 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 521,739 acquired | 5.75 | 2,999,999.25 | Form 4, filing 0000919574-26-000779 | |
| 2026-02-10 |
Insight Molecular Diagnostics Inc. IMDX |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-26-000779 | |
| 2026-01-09 |
Staar Surgical Co STAA |
P, Open-market purchase | 27,485 acquired | 22.05 | 606,137.70 | Form 4, filing 0001213900-26-004132 | |
| 2026-01-09 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-26-004132 | |
| 2026-01-08 |
Staar Surgical Co STAA |
P, Open-market purchase | 3,240 acquired | 21.94 | 71,082.04 | Form 4, filing 0001213900-26-002643 | |
| 2026-01-08 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-26-002643 | |
| 2026-01-07 |
Staar Surgical Co STAA |
P, Open-market purchase | 66,467 acquired | 22.00 | 1,462,300.59 | Form 4, filing 0001213900-26-002643 | |
| 2026-01-07 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-26-002643 | |
| 2026-01-06 |
Staar Surgical Co STAA |
P, Open-market purchase | 186,946 acquired | 21.01 | 3,927,941.10 | Form 4, filing 0001213900-26-002643 | |
| 2026-01-06 |
Staar Surgical Co STAA |
P, Open-market purchase | 150,000 acquired | 22.38 | 3,356,340.00 | Form 4, filing 0001213900-26-002643 | |
| 2026-01-06 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-26-002643 | |
| 2026-01-06 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-26-002643 | |
| 2025-11-21 |
Staar Surgical Co STAA |
P, Open-market purchase | 797,486 acquired | 27.86 | 22,218,837.19 | Form 4, filing 0001213900-25-113799 | |
| 2025-11-21 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-25-113799 | |
| 2025-11-20 |
Staar Surgical Co STAA |
P, Open-market purchase | 393,382 acquired | 27.14 | 10,675,325.35 | Form 4, filing 0001213900-25-113799 | |
| 2025-11-20 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-25-113799 | |
| 2025-11-19 |
Staar Surgical Co STAA |
P, Open-market purchase | 309,132 acquired | 26.42 | 8,166,154.56 | Form 4, filing 0001213900-25-113799 | |
| 2025-11-19 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0001213900-25-113799 | |
| 2025-04-10 |
Staar Surgical Co STAA |
P, Open-market purchase | 900 acquired | 15.18 | 13,658.04 | Form 4, filing 0000919574-25-002400 | |
| 2025-04-10 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-25-002400 | |
| 2025-04-09 |
Staar Surgical Co STAA |
P, Open-market purchase | 8,200 acquired | 15.08 | 123,675.68 | Form 4, filing 0000919574-25-002400 | |
| 2025-04-09 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-25-002400 | |
| 2025-04-08 |
Staar Surgical Co STAA |
P, Open-market purchase | 166,527 acquired | 15.28 | 2,544,032.98 | Form 4, filing 0000919574-25-002400 | |
| 2025-04-08 |
Staar Surgical Co STAA |
P, Open-market purchase | 11,600 acquired | 15.95 | 185,061.76 | Form 4, filing 0000919574-25-002400 | |
| 2025-04-08 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-25-002400 | |
| 2025-04-08 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-25-002400 | |
| 2025-04-07 |
Staar Surgical Co STAA |
P, Open-market purchase | 126,465 acquired | 15.58 | 1,969,970.60 | Form 4, filing 0000919574-25-002317 | |
| 2025-04-07 |
Staar Surgical Co STAA |
P, Open-market purchase | 11,589 acquired | 15.98 | 185,203.81 | Form 4, filing 0000919574-25-002317 | |
| 2025-04-07 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-25-002317 | |
| 2025-04-07 |
Staar Surgical Co STAA |
P, Open-market purchase | 0 acquired | Not reported | Not priced | Form 4, filing 0000919574-25-002317 | |
| 2025-04-04 |
Staar Surgical Co STAA |
P, Open-market purchase | 492,631 acquired | 15.90 | 7,834,901.95 | Form 4, filing 0000919574-25-002317 | |
| 2025-04-04 |
Staar Surgical Co STAA |
P, Open-market purchase | 5,000 acquired | 16.46 | 82,289.50 | Form 4, filing 0000919574-25-002317 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. BROADWOOD CAPITAL INC, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001278387
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6